Rekover Therapeutics
Pharmaceuticals - Wellington, Wellington, New Zealand
Rekover Therapeutics Employees
Rekover Therapeutics Details
Rekover Therapeutics is developing therapies for repair of tissue damage caused by multiple sclerosis. Our lead drug is a first-in-class, phase 2 ready molecule, with compelling preclinical data in two animal disease models and an excellent clinical safety profile. Rekover Therapeutics has assembled an experienced team with proven MS drug development credentials and deep expertise in the biology of remyelination. Patents are filed in key global territories protecting the technology. The company has short timelines and limited spend to proof of concept, with multiple strategic options following the POC study which is ready to operationalise in near COVID-19 free Australia and NZ
Rekover Therapeutics Technologies
Email Providers
Outlook
Advertising Networks
Google AdSense
Hosting
Google Cloud Hosting
Other
Mobile Friendly